VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+/calcineurin and protein kinase C-delta
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Yn: PLoS ONE, Cyfrol 5, Rhif 7, e11435, 06.07.2010.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+/calcineurin and protein kinase C-delta
AU - Holmes, Katherine
AU - Chapman, Elinor
AU - See, Violaine
AU - Cross, Michael J
PY - 2010/7/6
Y1 - 2010/7/6
N2 - BACKGROUND: Vascular endothelial growth factor (VEGF) has previously been shown to upregulate the expression of the endogenous calcineurin inhibitor, regulator of calcineurin 1, variant 4 (RCAN1.4). The aim of this study was to determine the role and regulation of VEGF-mediated RCAN1.4 expression, using human dermal microvascular endothelial cells (HDMECs) as a model system.METHODOLOGY/PRINCIPAL FINDINGS: We show that VEGF is able to induce RCAN1.4 expression during cellular proliferation and differentiation, and that VEGF-mediated expression of RCAN1.4 was inhibited by the use of inhibitors to protein kinase C (PKC) and calcineurin. Further analysis revealed that siRNA silencing of PKC-delta expression partially inhibited VEGF-stimulated RCAN1.4 expression. Knockdown of RCAN1.4 with siRNA resulted in a decrease in cellular migration and disrupted tubular morphogenesis when HDMECs were either stimulated with VEGF in a collagen gel or in an endothelial/fibroblast co-culture model of angiogenesis. Analysis of intracellular signalling revealed that siRNA mediated silencing of RCAN1.4 resulted in increased expression of specific nuclear factor of activated T-cells (NFAT) regulated genes.CONCLUSIONS/SIGNIFICANCE: Our data suggests that RCAN1.4 expression is induced by VEGFR-2 activation in a Ca(2+) and PKC-delta dependent manner and that RCAN1.4 acts to regulate calcineurin activity and gene expression facilitating endothelial cell migration and tubular morphogenesis.
AB - BACKGROUND: Vascular endothelial growth factor (VEGF) has previously been shown to upregulate the expression of the endogenous calcineurin inhibitor, regulator of calcineurin 1, variant 4 (RCAN1.4). The aim of this study was to determine the role and regulation of VEGF-mediated RCAN1.4 expression, using human dermal microvascular endothelial cells (HDMECs) as a model system.METHODOLOGY/PRINCIPAL FINDINGS: We show that VEGF is able to induce RCAN1.4 expression during cellular proliferation and differentiation, and that VEGF-mediated expression of RCAN1.4 was inhibited by the use of inhibitors to protein kinase C (PKC) and calcineurin. Further analysis revealed that siRNA silencing of PKC-delta expression partially inhibited VEGF-stimulated RCAN1.4 expression. Knockdown of RCAN1.4 with siRNA resulted in a decrease in cellular migration and disrupted tubular morphogenesis when HDMECs were either stimulated with VEGF in a collagen gel or in an endothelial/fibroblast co-culture model of angiogenesis. Analysis of intracellular signalling revealed that siRNA mediated silencing of RCAN1.4 resulted in increased expression of specific nuclear factor of activated T-cells (NFAT) regulated genes.CONCLUSIONS/SIGNIFICANCE: Our data suggests that RCAN1.4 expression is induced by VEGFR-2 activation in a Ca(2+) and PKC-delta dependent manner and that RCAN1.4 acts to regulate calcineurin activity and gene expression facilitating endothelial cell migration and tubular morphogenesis.
KW - Anti-Bacterial Agents/pharmacology
KW - Calcimycin/pharmacology
KW - Calcineurin/metabolism
KW - Calcium/metabolism
KW - Cell Line
KW - Cell Proliferation/drug effects
KW - Cells, Cultured
KW - DNA-Binding Proteins
KW - Endothelial Cells/drug effects
KW - Humans
KW - Immunoblotting
KW - Intracellular Signaling Peptides and Proteins/genetics
KW - Muscle Proteins/genetics
KW - Phosphorylation/drug effects
KW - Protein Kinase C-delta/metabolism
KW - RNA, Small Interfering
KW - Reverse Transcriptase Polymerase Chain Reaction
KW - Signal Transduction/drug effects
KW - Tetradecanoylphorbol Acetate/analogs & derivatives
KW - Vascular Endothelial Growth Factor A/pharmacology
U2 - 10.1371/journal.pone.0011435
DO - 10.1371/journal.pone.0011435
M3 - Article
C2 - 20625401
VL - 5
JO - PLoS ONE
JF - PLoS ONE
SN - 1932-6203
IS - 7
M1 - e11435
ER -